Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12439-12447
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12439
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12439
Figure 2 Patient with hepatitis B cirrhosis was diagnosed with hepatocellular carcinoma, refractory ascites, and esophageal gastric-fundus variceal bleeding.
Patient underwent TACE after TIPS. A: Tumor lesion revealed by contrast-enhanced CT arterial phase (white arrow). B1: Obvious portal vein dilation (short white arrow) and gastric coronary vein varicosis (long white arrow). B2: Gastric coronary vein embolism (long black arrow) and distributary channel (short black arrow). C: Lodine oil deposited in the lesion after TACE, shown by CT (black arrow); ascites disappeared and distributary channel stent (white arrow). TACE: Transarterial chemoembolization; TIPS: Transjugular intrahepatic portosystemic shunt; CT: Computed tomography.
- Citation: Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol 2015; 21(43): 12439-12447
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12439.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12439